Atrial Fibrillation Clinical Trials in Rome
3 recruitingRome, Italy
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
Atrial Fibrillation (AF)Ischemic StrokeOral Anticoagulation+2 more
University of L'Aquila200 enrolled47 locationsNCT06823466
Recruiting
Not Applicable
Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
Atrial FibrillationAtrial Fibrillation (Paroxysmal)
Hospital Universitario 12 de Octubre440 enrolled17 locationsNCT06698159